Pal André Holme, PhD, MD1*, Robert Campbell Tait, MD2*, Christophe Combescure, PhD3*, Erik Berntorp, MD, PhD4, Annarita Tagliaferri5*, Peter Staritz, MD6*, Roger E.G. Schutgens, MD, PhD7, Robert Klamroth8*, Natascha Marquardt9*, Stephan Rauchensteiner10* and Philippe De Moerloose, MD, PhD11*
1Department of Haematology, Oslo University Hospital, Oslo, Norway
2Royal Infirmary, Glasgow, United Kingdom, Glasgow, United Kingdom
33University Hospital and Faculty of Medicine of Geneva, Geneva, Switzerland, Geneva, Switzerland
4Lund University, Malmö, Sweden, Malmö, Sweden
55University Hospital of Parma, Parma, Italy, Parma, Italy
6Kurpfalz Hospital and Hemophilia Center, Heidelberg, Germany, Heidelberg, Germany
7Hematology and Van Creveldkliniek, University Medical Center, Utrecht, Netherlands
8Vivantes Clinic Friedrichshain, Berlin, Germany
9Institute for Experimental Haematology and Transfusion Medicine, University Clinic, Bonn, Germany, Bonn, Germany
10Bayer Healthcare, Berlin, Germany., Berlin, Germany
11University Hospital and Faculty of Medicine of Geneva, Geneva, Switzerland, Geneva, Switzerland